eli-002
·Code: ELI-002
eli-002: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Elicio Therapeutics, Inc. (ELTX) | Phase 2 |
FDA Decisions
FDA_MeetingThe Company received supportive feedback regarding the Phase 3 registrational strategy for its ELI-002 product candidate.(ELTX)
Frequently asked questions
Who is developing eli-002?
eli-002 is being developed by Elicio Therapeutics, Inc..
What is eli-002's latest FDA decision?
The most recent tracked FDA decision for eli-002 is FDA_Meeting for The Company received supportive feedback regarding the Phase 3 registrational strategy for its ELI-002 product candidate., dated January 22, 2025.
Get deeper analysis on eli-002
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis